GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
REXAHN PHARMACEUTICL (RNN) [hlAlert]

Rexahn Pharmaceuticals, Inc. (Rexahn) is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for cancer, central nervous system (CNS) disorders, sexual dysfunction and other medical needs. The Company develops therapies that make
it possible to regain normalcy for patients suffering from disease. It has three drug candidates in Phase II clinical trials during the year ended December 31, 2008, and six or more other drug candidates in pre-clinical development. The Company?s clinical-stage pipeline products include Archexin, an anti-cancer Akt inhibitor; Serdaxin, an antidepressant and CNS Disorders drug, and Zoraxel, an erectile dysfunction (ED) and sexual dysfunction drug. Rexahn?s pre-clinical pipeline includes RX-0201-Nano, RX-0047-Nano, Nano-polymer Anticancer Drugs, RX-0183, RX-5902 and RX-3117.
.
( Total: 5 Current Stock Recommendations )
REXAHN PHARMACEUTICL   (5)
Hold 20% Buy 80%
Related companies
Abbott Laboratories   (29)
Sell Hold 24% Buy 69%
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
TONGITANG CHINESE ...   (2)
Hold 100%
Achillion ...   (15)
Sell Hold 27% Buy 67%
Alcon Inc   (11)
Hold 64% Buy 36%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Prestige Brand ...   (6)
Sell 17% Hold 50% Buy 33%
Show  

Date (ET)MemberRatingYTD
Gains
 
12/28/2012  
Buy
  
3/20/2015  
Buy
  
1/18/2012  
Hold
  
1/9/2014  
Buy
  
6/16/2011  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy